AI
AstroNova, Inc. (ALOT)·Q1 2026 Earnings Summary
Executive Summary
- Q1 FY26 revenue rose 14.4% YoY to $37.7M, with both segments growing double digits; GAAP operating income was $0.6M and GAAP net loss was $0.4M (-$0.05 per diluted share), while adjusted EBITDA improved 27.7% YoY to $3.1M and margin expanded 80 bps to 8.3% .
- Management reaffirmed FY26 guidance: revenue $160–$165M and adjusted EBITDA margin 8.5%–9.5%; effective tax rate ~25% and D&A ~$5M; capex expected to be < $2M in FY26 .
- Execution highlights: $1.9M annualized cost saves executed in Q1 toward a $3M plan; launched three next-gen Product ID solutions; won a renewed ~$10M five‑year defense contract with ~$1.7M expected in FY26 shipments; orders were $34.9M and backlog $25.5M .
- Call commentary flagged improving mix (Tufrider 42% of Q1 shipments; aiming to double by FY-end), 83% recurring revenue, and limited tariff impact mitigated by surcharges and supply flexibility—catalysts for margin recovery through FY26 .
What Went Well and What Went Wrong
What Went Well
- Double-digit growth in both segments: Product ID +13.4% to $26.3M and Aerospace +16.8% to $11.4M; aerospace operating profit rose 60.5% on higher volume .
- Strategic wins and product momentum: three next-gen Product ID launches (QL425, QL435, AJ800/VP‑800) and renewed ~$10M defense contract with ~$1.7M FY26 shipments; plus new wins with a multinational beauty company and a large U.K. private-label grocer .
- Cost actions underway: $1.9M of annualized savings executed in Q1; non‑GAAP operating income rose 13.4% YoY to $1.5M despite higher corporate costs; adjusted EBITDA up 27.7% YoY to $3.1M .
- Quote: “We implemented approximately $1.9 million of our previously announced $3 million annualized cost reduction plan…we expect to…substantially complete the full cost reduction plan” – CEO Greg Woods .
What Went Wrong
- Margin pressure and higher corporate costs: gross margin fell to 33.6% (from 36.3% YoY) due to acquisition dilution and mix; corporate expenses increased ~$1.6M (healthcare and professional fees), compressing GAAP operating income to $0.6M (vs $1.3M YoY) .
- Higher interest and GAAP loss: interest expense rose to $0.9M (from $0.5M YoY) tied to acquisition financing; GAAP net loss was $0.4M vs. $1.2M profit YoY .
- Backlog down and legacy drag: backlog declined to $25.5M vs. $28.3M at FY25 year‑end, and a legacy aerospace contract weighed on margins (expected to complete by end of Q2 FY26) .
Financial Results
Consolidated results vs prior year/quarter and vs estimates (if available)
*No S&P Global consensus available for Q1 FY26 EPS or revenue; values unavailable via GetEstimates.
Non‑GAAP adjustments in Q1 FY26 included: MTEX-related acquisition expenses ($0.34M), inventory step‑up ($0.06M), restructuring ($0.56M) → lifting Non‑GAAP operating income to $1.53M and Non‑GAAP net income to $0.35M .
Segment breakdown
Note: Q4 FY25 Product ID GAAP segment operating loss includes a $13.4M goodwill impairment largely associated with MTEX .
KPIs
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We delivered double‑digit growth in the quarter from both segments…implemented approximately $1.9 million of our previously announced $3 million annualized cost reduction plan.” – Greg Woods, CEO .
- “We have made significant progress advancing the new foundational technology gained with the MTEX acquisition…more robust, next‑generation print engine solution designed to enhance our customer’s experience while reducing their total cost of ownership.” – Greg Woods .
- “83% of the quarter’s revenue was recurring…We expect gross profit and margin to improve throughout fiscal 2026 as we increase the percentage of Tufrider sales and the next‑generation product ID printer sales and supplies.” – Tom DeByle, CFO .
- “Tufrider aerospace printers were 42% of the first quarter shipments…we remain on track to double the percentage by the fiscal year end.” – Tom DeByle .
Q&A Highlights
- There were no analyst questions on the call; management reiterated the strategy and reiterated FY26 guidance .
- Clarifications provided in prepared remarks: ~$1.7M of the renewed $10M defense contract expected to ship in FY26; Tufrider mix to increase through FY26; tariff impacts minimal with pricing actions and sourcing flexibility .
Estimates Context
- No S&P Global consensus was available for Q1 FY26 EPS or revenue; GetEstimates returned no values for Q1, so we cannot quantify beat/miss versus Street. Management’s FY26 guidance was reaffirmed, suggesting Street models likely maintain current revenue and EBITDA margin ranges .
- With cost savings realized from Q2 and mix shift (higher Tufrider, next‑gen Product ID), the margin trajectory cited by management implies upward bias to H2 margin assumptions, but absent consensus, formal revision magnitude cannot be assessed .
Note: S&P Global consensus values were unavailable via GetEstimates for the relevant period.
Key Takeaways for Investors
- Growth re-accelerated: Revenue +14.4% YoY with both segments contributing; adjusted EBITDA +27.7% YoY and margin +80 bps to 8.3%—evidence early restructuring and mix benefits are flowing through .
- Mix catalysts: Tufrider at 42% of shipments in Q1 with a plan to double by FY-end, plus a renewed $10M defense contract and new customer wins position Aerospace for sustained margin leverage .
- Product ID turnaround: Three next‑gen launches, expanded sales/distribution, and multi‑source ink strategy target higher-volume end markets and COGS control—supportive for recurring supplies growth and gross margin over FY26–27 .
- Cost-downs on track: $1.9M of $3M annualized savings already executed; full program targeted by Q2, providing incremental operating leverage as volumes build .
- Near-term watch items: Backlog decline to $25.5M and lingering legacy contract margin headwinds through Q2; monitor orders conversion, mix shift pace, and sequential margin expansion in Q2/Q3 .
- Balance sheet and liquidity: Q1 operating cash flow $4.4M; cash $5.35M; liquidity $12.6M including revolver availability; interest expense up with acquisition debt—leverage targeted toward ~2x over time .
- Guidance steady: FY26 revenue $160–$165M and adj. EBITDA margin 8.5%–9.5% reaffirmed; if execution stays on plan, margin upside in H2 could be a stock catalyst as mix/cost actions compound .